Montelukast Prescribing at THE NEW SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
998
Total Quantity
22.6K
NHS Cost
£1.2K
vs National Avg
+45.8%
THE NEW SURGERY prescribed 998 items of Montelukast over the last 12 months at a cost of £1,188 to the NHS. This is 45.8% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
94
Jul 2026
73
Jul 2026
89
Jul 2026
76
Jul 2026
71
Jul 2026
85
Jul 2026
85
Jul 2026
76
Jul 2026
96
Jul 2026
79
Jul 2026
90
Jul 2026
84
Prescribing Details
| Total Items | 998 |
|---|---|
| Total Quantity | 22,550 |
| Total NHS Cost | £1,188 |
| Presentations | 4 different forms |
| vs National Average | +45.8% |
Montelukast Prescribing Comparison
| This practice | 998 items |
|---|---|
| National average per practice | 685 items |
| Difference | +45.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.